Skip to main navigation
Logo
  • ABOUT
    • Corporate Overview
    • History
    • Executive Team
    • Board of Directors
    • Collaborations
    • Contact
  • PRODUCTS
    • Glatopa
    • Enoxaparin
  • PIPELINE
    • Pipeline
    • Biosimilars
      • Strategy
      • Development Program
    • Novel Products
      • Autoimmune Indications
    • Complex Generics
      • M356
  • TECHNOLOGY
    • Momenta Advantage
    • Intellectual Property
  • INVESTORS

    Investor Relations

    • Overview
    • Stock Information
      • Overview
      • Historic Stock Lookup
      • Analyst Coverage
    • Financials & Filings
      • Overview
      • SEC Filings
      • Annuals and Proxies
      • Quarterly Results
      • Key Ratios
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Overview
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Investor FAQs
    • Email and News Alerts
    • Contact Us
  • NEWS & PUBLICATIONS
    • News
    • Publications
  • CAREERS

Investors

Investors • SC 13G/A

SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
Jan 31, 2019
Document Date
Jan 31, 2019
Form Description
An amendment to the SC 13G filing
Filing Group
3,4,5
Company
Momenta Pharmaceuticals
Issuer
MOMENTA PHARMACEUTICALS INC

Filing Formats

View HTML
Download PDF
Download DOC

Shareholder Tools

  • Printed Materials
  • Email Alerts
  • Downloads
  • RSS
  • Print

Momenta® and the Momenta logo are registered trademarks of Momenta Pharmaceuticals, Inc.
© 2019 Momenta Pharmaceuticals - All Rights Reserved | Terms of Use | Privacy